CellSeed Inc. (7776.T)
JPY 535.0
(-1.47%)
JPY 535.0
(-1.47%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 190.13 Million JPY | 50.39% |
| 2022 | 126.42 Million JPY | -21.8% |
| 2021 | 161.67 Million JPY | -18.95% |
| 2020 | 199.46 Million JPY | -27.68% |
| 2019 | 275.82 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 42.06 Million JPY | 22.86% |
| 2024 Q1 | 34.23 Million JPY | -51.73% |
| 2023 Q2 | 36.27 Million JPY | 18.16% |
| 2023 Q4 | 70.93 Million JPY | 35.79% |
| 2023 FY | 190.13 Million JPY | 50.39% |
| 2023 Q1 | 30.69 Million JPY | -19.73% |
| 2023 Q3 | 52.23 Million JPY | 44.02% |
| 2022 Q3 | 13.57 Million JPY | 0.0% |
| 2022 FY | 126.42 Million JPY | -21.8% |
| 2022 Q4 | 38.24 Million JPY | 181.75% |
| 2021 FY | 161.67 Million JPY | -18.95% |
| 2020 FY | 199.46 Million JPY | -27.68% |
| 2019 FY | 275.82 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 96.014% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -68.37% |
| GNI Group Ltd. | 26.01 Billion JPY | 99.269% |
| Linical Co., Ltd. | 12.3 Billion JPY | 98.455% |
| Trans Genic Inc. | 13.08 Billion JPY | 98.547% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 71.259% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 96.314% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 87.815% |
| AnGes, Inc. | 152.98 Million JPY | -24.283% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 68.837% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 98.511% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 76.719% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -40.312% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 88.306% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | 55.614% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 89.999% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 72.14% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 92.18% |
| PeptiDream Inc. | 28.71 Billion JPY | 99.338% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -201.618% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -57.136% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -263975.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -376.682% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 95.785% |
| FunPep Company Limited | 530 Thousand JPY | -35774.34% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -174.562% |
| Stella Pharma Corporation | 269.49 Million JPY | 29.447% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | 39.986% |
| Cuorips Inc. | 23.1 Million JPY | -723.02% |
| K Pharma,Inc. | 1 Billion JPY | 80.987% |
| Takara Bio Inc. | 43.5 Billion JPY | 99.563% |
| ReproCELL Incorporated | 2.42 Billion JPY | 92.165% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 88.916% |
| StemCell Institute Inc. | 2.48 Billion JPY | 92.337% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 92.438% |